SENSEX NIFTY

Us Food And Drug Administration

Jan 19, 2017 at 14:03 | Source: CNBC-TV18
The company Wednesday received the US Food and Drug Administration (USFDA) approval for an anti-migraine drug for which it had filed the Abbreviated New Drug Application (ANDA) in 2012.
Jan 19, 2017 at 12:33 | Source: Moneycontrol.com
The US drug regulator gave a tentative nod for the company's Olmesartan Medoxomil tablets, which is used to treat blood pressure.
Jan 13, 2017 at 12:44 | Source: PTI
The company said it has launched the morphine sulfate ER Tablets in strengths of 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from the US Food and Drug Administration (USFDA).
Jan 13, 2017 at 12:30 | Source: Moneycontrol.com
The company has launches Morphine Sulfate ER tablets 15 mg, 30 mg, 60 mg, 100 mg and 200 mg having received an approval from United State Food and Drug Administration (USFDA).
Jan 12, 2017 at 15:34 | Source: PTI
US Food and Drug Administration (USFDA) will re-audit three manufacturing facilities of Dr Reddy's Laboratories in the current quarter.
Jan 11, 2017 at 14:40 | Source: PTI
Lupin said in a BSE filing that it "has received final approval for its Desoximetasone cream USP, 0.05 percent and Desoximetasone cream USP, 0.25 percent from the United States Food and Drug Administration (USFDA)".
Jan 09, 2017 at 10:00 | Source: CNBC-TV18
Valuation in the information technology sector is favourable but challenges in terms of earnings and uncertainty on Trumps policies make them good picks only on bad days, says Nischal Maheshwari, Head - Institutional Equities at Edelweiss Securities.
Jan 06, 2017 at 14:56 | Source: PTI
"Pursuant to the settlement of the Paragraph IV litigation, Natco plans to launch this drug on November 1, 2019, or earlier under certain circumstances, through its marketing partner Breckenridge Pharmaceutical, Inc in the USA market," it added.
Jan 06, 2017 at 14:22 | Source: PTI
According to a statement issued by the city-based drug-maker, the drug will be launched along with its marketing partner Breckenridge Pharmaceutical Inc and will have 180-days exclusivity.
Jan 06, 2017 at 13:09 | Source: Moneycontrol.com
Natco Pharma is pleased to announce the final approval of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the U.S. Food and Drug Administration (FDA) for generic version of Bendamustine Hydrochloride powder for Injection, 25 mg/Vial and 100 mg/Vial (Singe-Dose Vial).
Messages on Us Food And Drug Administration »

Chari_2014

New Member

7 Followers

Panacea Biotec  

in a sustainable manner in mid to long term. The Capital-based firm has received approval from the US Food and Drug Administration (USFDA) to market its generic product to treat migraine in strenghts of 5 and 10 mg, Panacea Biotec said in a statement. Panacea`s product is equivalent to Merck & Co`s Maxalt

12.27 PM Jan 19th

k.v.renga

Platinum Member

1368 Followers

Panacea Biotec  

Source:----BL:----) January 18, 2017: Panacea Biotec on Wednesday said the US Food and Drug Administration has approved the company s abbreviated new drug application for rizatritan benzoate orally disintegrating tablets of 5 mg and 10 mg strengths, which is the generic equivalent of Maxalt

9.26 PM Jan 18th

Wire News

Platinum Member

694 Followers

News Now  

US Food and Drug Administration (USFDA) will re-audit three manufacturing facilities of Dr Reddy's Laboratories in the current quarter.

3.34 PM Jan 12th

bseguru17

New Member

0 Follower

Natco Pharma  

Following the approval from the US Food and Drug Administration for its generic version of Bendamustine Hydrochloride powder for injection, 25 mg/vial and 100 mg/vial (singe-dose vial), Natco Pharma will launch the drug on November 1, 2019 or earlier in the US market.

4.38 PM Jan 10th

ahaslaltirm
a

Platinum Member

878 Followers

Wockhardt  

will continue to supply of APIs across European Union that contributed about 37 percent of company`s revenue in FY16. Three days back, the same active pharmaceutical ingredient plant had received a warning letter from the US Food and Drug Administration. The USFDA had imposed import alert on the company

2.03 PM Jan 9th

Wire News

Platinum Member

694 Followers

News Now  

Natco Pharma Ltd today said following the approval from US Food and Drug Administration for its generic version of Bendamustine Hydrochloride powder for injection, 25 mg/Vial and 100 mg/Vial (Singe-Dose Vial), it will launch the drug on November 1, 2019 or earlier in USA market.

2.22 PM Jan 6th

Wire News

Platinum Member

694 Followers

News Now  

The US Food and Drug Administration (USFDA) has issued a warning letter to Wockhardt for violating current good manufacturing practice norms, including its failure to ensure proper clothing for workers at its Ankleshwar plant in Gujarat.

2.44 PM Jan 4th

diyapilly

New Member

2 Followers

Glenmark  

new delhi: glenmark pharmaceuticals has received a final approval from the us food and drug administration (fda) for sale of tretinoin capsules, used in treatment of leukemia. big news target rerated at 950 soon intraday target 915 930 945

10.42 AM Jan 2nd

kalpataru70

Platinum Member

497 Followers

Aurobindo Pharm  

Aurobindo Pharma has received US Food and Drug Administration`s (USFDA) approval for two of its generic drugs, following which the company stocks gained positive traction. Ziprasidone Hydrochloride, marketed by Pfizer, is used for the treatment of schizophrenia and acute mania. Indomethacin, which

2.23 PM Dec 30th 2016

sohal.manpr
eet

New Member

0 Follower

Divis Labs  

On December 7, 2016, the US Food and Drug Administration (USFDA) had issued form 483 with many observations against Divi`s . Observation letter highlights serious issues like disregard of unknown impurities without specific justification. This coupled with others can attract an import ban

10.24 AM Dec 27th 2016

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.